TNFRSF4 and autoimmune thrombocytopenic purpura: The results showed remarkably elevated expression levels of OX40 and OX40L mRNA in ITP patients compared with the HCs; in particular, a noticeable difference was observed between ITP patients with positive and negative antiplatelet autoantibodies (Figures 4(a) and 4(b)).